Agency Forms Undergoing Paperwork Reduction Act Review, 71275-71276 [2024-19611]
Download as PDF
71275
Federal Register / Vol. 89, No. 170 / Tuesday, September 3, 2024 / Notices
• Request for Medical Records
Form—Miners wishing to receive copies
of their CWHSP chest x-rays and related
files must fully complete, sign, and
email this form to cwhsp@cdc.gov. The
form can also be mailed or faxed using
the address and fax listed on the form.
It is estimated that five minutes is
required for the coal miner to complete
this form.
There are no costs to respondents
other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)
No. of
responses per
respondent
Total
burden
hours
Form name
Coal mine operator .............................
Coal Mine Contractor ..........................
Radiograph Facility Supervisor ...........
Coal Miner ..........................................
Coal Miner—Radiograph ....................
B Reader Physician ............................
Qualified and Licensed Physician
(NIOSH Approved Radiograph Facility).
Physicians taking the B Reader Examination.
Spirometry Facility Supervisor ............
Spirometry Facility Employee .............
Spirometry Technician ........................
Coal Miner—Spirometry .....................
Request for Medical Records .............
Pathologist ..........................................
Pathologist ..........................................
Pathologist ..........................................
Next-of-kin for deceased miner ..........
2.10 .....................................................
2.18 .....................................................
2.11 .....................................................
2.9 .......................................................
No form required ................................
2.8 .......................................................
2.8 .......................................................
268
165
20
4,345
4,788
10
4,788
1
1
1
1
1
899
1
30/60
30/60
30/60
20/60
15/60
3/60
3/60
134
83
10
1,448
1,197
450
240
2.12 .....................................................
110
1
10/60
18
2.14 .....................................................
2.13 .....................................................
2.15 .....................................................
No form required ................................
Request for Medical Records Form ...
2.19 .....................................................
Invoice—No standard form ................
Pathology Report—No standard form
2.6 .......................................................
15
619
619
619
779
4
4
4
4
1
1
1
1
1
1
1
l
1
30/60
5/60
20/60
15/60
5/60
15/60
5/60
5/60
15/60
8
52
206
155
65
1
1
1
1
Total .............................................
.............................................................
........................
............................
....................
4,070
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–19614 Filed 8–30–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day-24–23IE]
Agency Forms Undergoing Paperwork
Reduction Act Review
tkelley on LAP7H3WLY3PROD with NOTICES2
No. of
respondents
Type of respondent
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Social and
Economic Barriers to Receiving Optimal
Services Along the Cancer Care
Continuum’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on
September 26, 2023 to obtain comments
from the public and affected agencies.
CDC did not receive comments related
to the previous notice. This notice
VerDate Sep<11>2014
22:46 Aug 30, 2024
Jkt 262001
serves to allow an additional 30 days for
public and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Social and Economic Barriers to
Receiving Optimal Services Along the
Cancer Care Continuum—New—
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The purpose of this project is to: (1)
examine and better understand social
and economic barriers faced by
colorectal, breast, and cervical cancer
survivors and their caregivers at each
stage of the Cancer Care Continuum
(CCC); and (2) quantify the impact of
U:\REGISTER\03SEN1.SGM
03SEN1
71276
Federal Register / Vol. 89, No. 170 / Tuesday, September 3, 2024 / Notices
individual and compounded barriers on
health outcomes along the CCC for
survivors. CDC will use a mixed
methods data collection and analysis
approach. First, CDC will pull our
sample from cancer registry data in
California, North Carolina, and Texas
based on inclusion criteria (received
first cancer diagnosis of either breast,
cervical or colorectal cancer in 2021;
21–75 years of age at time of diagnosis;
are non-Hispanic Black/African
American, non-Hispanic White, or
Hispanic; alive at the time of data
extraction/sample selection). Then, CDC
will administer a Wave 1 (baseline) and
Wave 2 (one-year follow-up) survey to
cancer survivors, as well as a survey to
their caregivers. Additionally, CDC will
conduct interviews with selected
survivors and caregivers as well as focus
groups with representatives from
patient/survivor advocacy
organizations.
CDC will incorporate cancer registry
data into the quantitative data analysis,
and triangulate findings from the
quantitative and qualitative data
collection efforts. Results will be used to
inform efforts aimed at increasing access
to cancer care services, reducing the
burden of cancers and closing the
disparities gap. CDC requests OMB
approval for an estimated 1,681 annual
burden hours. There are no costs to
respondents other than their time to
participate.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Wave 1 Survivor Survey Respondents ...........
Wave 2 Survivor Survey Respondents ...........
Survivor Interviewees ......................................
Caregiver Survey Respondents ......................
Caregiver Interviewees ...................................
Patient Advocacy Group—Focus Group Participants.
W1 Survey Instrument ...................................
W2 Survey Instrument ...................................
Survivor Interview Guide ................................
Caregiver Survey Instrument .........................
Caregiver Interview Guide .............................
Advocacy Representatives Focus Group
Guide.
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–19611 Filed 8–30–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2024–0063]
Meeting of the Advisory Committee to
the Director (ACD), Centers for Disease
Control and Prevention
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
Notice of meeting and request
for comment.
ACTION:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting for the Advisory
Committee to the Director, Centers for
Disease Control and Prevention (ACD,
CDC). This is a hybrid meeting,
accessible both in person and virtually
(webcast live via the World Wide Web).
It is open to the public and limited only
by the space available.
tkelley on LAP7H3WLY3PROD with NOTICES2
SUMMARY:
VerDate Sep<11>2014
22:46 Aug 30, 2024
Jkt 262001
The meeting will be held on
October 22, 2024, from 9 a.m. to 3:30
p.m., EDT (times subject to change).
The public may submit written
comments from September 3, 2024
through October 7, 2024.
ADDRESSES: Meeting address: CDC
Roybal Campus, Building 19,
Auditorium B3, 1600 Clifton Road NE,
Atlanta, Georgia 30329–4027.
Please note that the meeting location,
the CDC Roybal Campus, is a federal
facility and in-person access is limited
to United States citizens unless prior
authorizations, taking up to 30 to 60
days, have been made.
Registration: You must register to
attend this meeting in person. If you
wish to attend in person, please submit
a request by email to ACDirector@
cdc.gov at least 5 business days in
advance of the meeting. No registration
is required to view the meeting via the
World Wide Web. Information for
accessing the webcast will be available
at https://www.cdc.gov/about/advisorycommittee-director/.
Written comments: You may submit
comments, identified by Docket No.
CDC–2024–0063 by either of the
following methods below. Do not
submit comments for the docket by
email. CDC does not accept comments
for the docket by email.
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Demetria Gardner, BA,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE,
DATES:
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Number of
respondents
Type of respondents
3,000
1,200
20
900
20
16
1
1
1
1
1
1
Average
burden per
response
(in hours)
20/60
20/60
1
15/60
1
1
Mailstop H21–10, Atlanta, Georgia
30329–4027. Attn: Docket number CDC–
2024–0063.
Instructions: All submissions received
must include the Agency name and
Docket Number. All relevant comments
received in conformance with the
https://www.regulations.gov, suitability
policy will be posted without change to
https://www.regulations.gov, including
any personal information provided. For
access to the docket to read background
documents or comments received, go to
https://www.regulations.gov. Written
public comments submitted up to 72
hours prior to the ACD meeting will be
provided to ACD members before the
meeting. Written comments received in
advance of the meeting will be included
in the official record of the meeting.
FOR FURTHER INFORMATION CONTACT:
Demetria Gardner, BA, Office of the
Chief of Staff, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, Mailstop H21–10, Atlanta,
Georgia 30329–4027, Telephone: (770)
488–4745; Email Address: ACDirector@
cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Advisory Committee to
the Director, CDC, shall (1) make
recommendations to the Director
regarding ways to prioritize the
activities of the agency in alignment
with the CDC Strategic Plan required
under section 305(c); H.R. 2617–1252;
(2) advise on ways to achieve or
improve performance metrics in relation
to the CDC Strategic Plan, and other
relevant metrics, as appropriate; (3)
U:\REGISTER\03SEN1.SGM
03SEN1
Agencies
[Federal Register Volume 89, Number 170 (Tuesday, September 3, 2024)]
[Notices]
[Pages 71275-71276]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-19611]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-24-23IE]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Social and Economic Barriers to Receiving
Optimal Services Along the Cancer Care Continuum'' to the Office of
Management and Budget (OMB) for review and approval. CDC previously
published a ``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on September 26, 2023 to obtain comments from
the public and affected agencies. CDC did not receive comments related
to the previous notice. This notice serves to allow an additional 30
days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Social and Economic Barriers to Receiving Optimal Services Along
the Cancer Care Continuum--New--National Center for Chronic Disease
Prevention and Health Promotion (NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The purpose of this project is to: (1) examine and better
understand social and economic barriers faced by colorectal, breast,
and cervical cancer survivors and their caregivers at each stage of the
Cancer Care Continuum (CCC); and (2) quantify the impact of
[[Page 71276]]
individual and compounded barriers on health outcomes along the CCC for
survivors. CDC will use a mixed methods data collection and analysis
approach. First, CDC will pull our sample from cancer registry data in
California, North Carolina, and Texas based on inclusion criteria
(received first cancer diagnosis of either breast, cervical or
colorectal cancer in 2021; 21-75 years of age at time of diagnosis; are
non-Hispanic Black/African American, non-Hispanic White, or Hispanic;
alive at the time of data extraction/sample selection). Then, CDC will
administer a Wave 1 (baseline) and Wave 2 (one-year follow-up) survey
to cancer survivors, as well as a survey to their caregivers.
Additionally, CDC will conduct interviews with selected survivors and
caregivers as well as focus groups with representatives from patient/
survivor advocacy organizations.
CDC will incorporate cancer registry data into the quantitative
data analysis, and triangulate findings from the quantitative and
qualitative data collection efforts. Results will be used to inform
efforts aimed at increasing access to cancer care services, reducing
the burden of cancers and closing the disparities gap. CDC requests OMB
approval for an estimated 1,681 annual burden hours. There are no costs
to respondents other than their time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Wave 1 Survivor Survey Respondents.... W1 Survey Instrument.... 3,000 1 20/60
Wave 2 Survivor Survey Respondents.... W2 Survey Instrument.... 1,200 1 20/60
Survivor Interviewees................. Survivor Interview Guide 20 1 1
Caregiver Survey Respondents.......... Caregiver Survey 900 1 15/60
Instrument.
Caregiver Interviewees................ Caregiver Interview 20 1 1
Guide.
Patient Advocacy Group--Focus Group Advocacy Representatives 16 1 1
Participants. Focus Group Guide.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-19611 Filed 8-30-24; 8:45 am]
BILLING CODE 4163-18-P